Endo International plc, along with its affiliates, filed a joint plan of reorganization with related disclosure statement in the US Bankruptcy Court on December 19, 2023. As per the plan filed, administrative expense claims, fee claims, restructuring expenses, Non-IRS priority tax claims, IRS priority tax claims, priority non-tax claims, other secured claims, shall be paid in full in cash. First Lien Claims of $5,862.68 million shall receive its pro rata share of 96.30% of the purchaser equity, if the exit minimum cash sweep trigger occurs, cash from the exit minimum cash sweep; and/or the net proceeds of the Syndicated Exit Financing, if any, after giving effect to the transactions occurring on the Effective Date; and/or the new takeback debt; the first lien accrued and unpaid adequate protection payments; and the first lien subscription rights.

Second lien deficiency claims of $940.59 million and Unsecured notes claims of $1,344.56 million shall receive GUC subscription rights. Other general unsecured claims shall receive their pro rata share of GUC trust consideration. Mesh claims shall automatically, and without further act, deed, or court order, be channeled exclusively to the GUC Trust and all of the Debtors?

liability for such Claim shall be assumed by the GUC Trust. Mesh Claims shall be exclusively handled by the Mesh Claims Trust, which shall be funded with the Mesh Claims Trust Consideration in accordance with the Mesh Claims Trust Documents, and Mesh Claims shall be treated solely in accordance with the terms, provisions, and procedures of the Mesh Claims Trust Documents, which shall provide that Mesh Claims shall be either Allowed and administered by the Mesh Claims Trust or otherwise Disallowed and released in full. Ranitidine Claims shall automatically, and without further act, deed, or court order, be channeled exclusively to the GUC Trust and all of the Debtors?

liability for such Claim shall be assumed by the GUC Trust. Ranitidine Claims shall be exclusively handled by the Ranitidine Claims Trust, which shall be funded with the Ranitidine Claims Trust Consideration in accordance with the Ranitidine Claims Trust Documents, and Ranitidine Claims shall be treated solely in accordance with the terms, provisions, and procedures of the Ranitidine Claims Trust Documents, which shall provide that Ranitidine Claims shall be either Allowed and administered by the Ranitidine Claims Trust or otherwise Disallowed and released in full. Generics Price Fixing Claims shall receive the GUC Trust Consideration, including the Generics Price Fixing Claims Trust Consideration, in accordance with the Generics Price Fixing Claims Trust Documents; and each Generics Price Fixing Claim shall automatically, and without further act, deed, or court order, be channeled exclusively to the GUC Trust and all of the Debtors?

liability for such Claim shall be assumed by the GUC Trust. Generics Price Fixing Claims shall be exclusively handled by the Generics Price Fixing Claims Trust, which shall be funded with the Generics Price Fixing Claims Trust Consideration in accordance with the Generics Price Fixing Claims Trust Documents, and Generics Price Fixing Claims shall be treated solely in accordance with the terms, provisions, and procedures of the Generics Price Fixing Claims Trust Documents, which shall provide that Generics Price Fixing Claims shall be either Allowed and administered by the Generics Price Fixing Claims Trust or otherwise Disallowed and released in full. Reverse Payment Claims shall automatically, and without further act, deed, or court order, be channeled exclusively to the GUC Trust and and all of the Debtors?

liability for such Claim shall be assumed by the GUC Trust. U.S. Government Claims shall receive the U.S. Government resolution consideration. State Opioid Claims shall receive the Public Opioid Consideration in accordance with the Public Opioid Distribution Documents; and each State Opioid Claim shall automatically, and without further act, deed, or court order, be channeled exclusively to the Public Opioid Trust and all of the Debtors?

liability for such Claim shall be assumed by the Public Opioid Trust. Local Government Opioid Claims shall be eligible to receive distributions from their respective State in accordance with such State?s opioid abatement programs. Tribal Opioid Claims shall receive the Tribal Opioid Consideration in accordance with the Tribal Opioid Distribution Documents. PI Opioid Claims shall receive the PI Trust Share in accordance with the PI Trust Documents.

NAS PI Claims shall receive the NAS PI Trust Share in accordance with the NAS PI Trust Documents. Hospital Opioid Claims shall receive the Hospital Trust Share in accordance with the Hospital Trust Documents. TPP Claims shall receive the TPP Trust Share in accordance with the TPP Trust Documents.

IERP II Claims shall receive the IERP Trust II Share in accordance with the IERP Trust II Documents. Public School District Claims, the Special Education Initiative shall be funded with the Special Education Initiative Consideration in accordance with the Special Education Initiative Governing Documents. Canadian Governments claims shall receive the Canadian Governments Consideration in accordance with the Canadian Governments Distribution Documents, pursuant to which the aggregate amount of Canadian Governments Consideration shall be subject to adjustment depending on the number of holders of Allowed Canadian Governments Claims that grant the Non-GUC Releases.

Settling Co-Defendant Claims shall be released. Other Opioid Claims shall receive its pro rata share of other opioid consideration. Intercompany claims shall be reinstated.

Intercompany interests shall either be transferred, directly or indirectly, to the applicable Purchaser Entities; reinstated; or deemed automatically cancelled. Subordinated, Recharacterized, or Disallowed Claims shall be cancelled and shall not receive any distribution under the plan. Existing equity interests shall be cancelled.

The plan shall be funded through cash, the Exit Financing or the proceeds thereof, Purchaser Equity, the GUC Trust Litigation Consideration.